Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program.
The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.
Grundy
S M
SM
National Cholesterol Education Program, National Heart, Lung, and Blood Institute, Bethesda, MD 20892-2480, USA.
Cleeman
J I
JI
Rifkind
B M
BM
Kuller
L H
LH
D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood*; D002986:Clinical Trials as Topic; D017023:Coronary Angiography; D003327:Coronary Disease / Q000097:blood / Q000000981:diagnostic imaging / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood* / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D018579:Patient Selection; D012307:Risk Factors; D012737:Sex Factors; D014481:United States
D000924:Anticholesteremic Agents; D002784:Cholesterol